Clinical use of non-a botulinum toxins: Botulinum toxin type C and botulinum toxin type F
Copyright policy )Clinical use of non-a botulinum toxins: Botulinum toxin type C and botulinum toxin type F
Botulinum neurotoxin (BoNT) serotype A is commonly used in the treatment of focal dystonia, but some patients are primarily or become secondarily resistant to it. Consequently, other serotypes have to be used when immuno-resistance is proven. In the literature, patients with focal dystonia have been treated with BoNT serotype F with clinical benefit but with short lasting effects. Recently, BoNT serotype C has been used with positive clinical outcome. An update on the clinical use of BoNT serotype F and BoNT serotype C is provided.
- University of Rostock Germany
- University of Padua Italy
- Anna University, Chennai India
Adult, Male, Mice, Inbred BALB C, Botulinum Toxins, Muscle Weakness, Drug Resistance, Middle Aged, Mice, Animals, Blepharoptosis, Humans, Female, Torticollis, Aged
Adult, Male, Mice, Inbred BALB C, Botulinum Toxins, Muscle Weakness, Drug Resistance, Middle Aged, Mice, Animals, Blepharoptosis, Humans, Female, Torticollis, Aged
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).49 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!